Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 30 Apr 2026 Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination npj Antimicrobials and Resistance
In the media 29 Apr 2026 ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด Thai Rath
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 25 Apr 2026 ‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África Alma Preta
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Scientific articles 14 Apr 2026 Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis Clinical and Translational Science
In the media 11 Apr 2026 Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record Le Monde
Press releases 24 Nov 2020 Largest clinical trial in Africa to treat COVID-19 cases before they become severe is launched in 13 countries
Press releases 12 Nov 2020 Thailand’s Prince Mahidol Award honours Dr Bernard Pécoul, Founder of DNDi, for his service to public health
Press releases 13 Oct 2020 COVID-19: first set of specific healthcare recommendations issued for people living with Chagas disease
Press releases 1 Oct 2020 DNDi welcomes GHIT Fund support for Phase I trial of novel treatment for cutaneous leishmaniasis
Press releases 29 Sep 2020 DRC: The Ministry of Health and DNDi launch a project designed to facilitate access to new treatments against sleeping sickness
Press releases 28 Sep 2020 Fundación MEDINA, DNDi, and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease
Press releases 4 Sep 2020 Innovative single-dose oral sleeping sickness treatment to be co-developed by Sanofi and DNDi partnership
Press releases 13 May 2020 DNDi short film about new treatment for sleeping sickness awarded Grand Prix at inaugural WHO film festival
Press releases 14 Apr 2020 Up to 45,000 people living with Chagas disease in the US at risk of severe COVID-19 complications
Press releases 13 Apr 2020 Marking World Chagas Day for the first time to help give visibility to this neglected disease
Press releases 2 Apr 2020 Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries
Press releases 25 Feb 2020 Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis
Press releases 5 Dec 2019 Brazil’s Ministry of Health and CNPq to invest in researching new treatments for leishmaniasis and Chagas disease
Press releases 28 Nov 2019 Public-private partnership launched to develop new drugs for roundworm infections
Press releases 27 Nov 2019 Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million